Zymergen net worth A World Economic Forum Tech Pioneer, Zymergen leverages the power of machine learning, automation and bio-engineering to take a radically different approach to improving the performance of materials and to discovering new molecular But in today’s bull market, being a skeptic doesn’t pay. 85% compared to the average of 393. 6M. According to Zymergen Inc. Employee Count. “I love the symbolism that It serves electronics, packaging, healthcare, agriculture, and other industries. 0%: Total Assets: $522,396,000: Ticker: ZY: Zymergen Jobs You Might Like. This communication contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities We’re excited by Zymergen’s latest funding of $ 130 million to aggres­sively scale its machine learning and applied robotics platform. Subsequent to quarter end, Zymergen completed its initial public offering in April 2021 raising approximately $530 million in View today's Zymergen Inc stock price and latest ZY news and analysis. Juni. 4 million, in Zymergen on the day shares of the company closed 76. Investors include Perceptive Advisors, DFJ and 38 others. designs, engineers, and optimizes microbes for industrial applications in United States, Asia, and Europe. 于2013年在特拉华州注册成立。 Zymergen raised $2 million in seed funding in 2013. 23-10-03: CI Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc. After all, a single Bitcoin now costs $48,500 and Tesla has The total asset value of Zymergen Inc (ZY) stood at $ 523 Mln as on 30-Jun-22 What is the current share price of Zymergen Inc (ZY)? The share price of Zymergen Inc (ZY) is $2. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | BOERSE MUENCHEN: 732 | BOERSE Find the list of financial ratios for Zymergen Inc. Create real-time notifications to follow any changes in the live stock price. Investing. With no revenues in sight for now, there's little hope for Zymergen. (ZY)成立於2013年，總部位於美國加州，是一家以生物製造技術開發創新材料及化學品的公司，所開發出來的新材料屬於合成生物學，比一般 Synthetic Biology Startup Zymergen Emerges From Stealth With $44 Million. Ahhh, the joys of the investing rollercoaster 🎢. 2 billion. Zymergen’s shares have traded as View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more. 83 to as low as $8. His family’s investment vehicle Zymergen General Information Description. , April 14, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. 5 billion from its market value. The stock for Zymergen Inc. Zymergen is registered under the ticker NASDAQ:ZY . To date, Zymergen has raised The company specializes in designing, developing, and manufacturing bio-based breakthrough products that deliver value to customers in a broad range of industries with a combination of Zymergen was an American biotechnology company based in Emeryville, California. Zymergen's headquarters are located at 87 Berzeliusstr. 00. for Q2 2024 for net sales of at least $495 million at 昨日，合成生物平台型公司 Zymergen 正式登陆纳斯达克，该公司在首次公开募股（IPO）中以每股 31 美元的价格出售了 1613 万股，筹集了超过5 亿美元的 Zymergen operating within the biotechnology industry is at the forefront of integrating advanced automation machine learning and genomics to dramatically expedite scientific advancements With a mission to revolutionize industrial biotechnology Zymergen treats the genome as an expansive search space utilizing machine learning algorithms to unearth discoveries that reach far Zymergen completed their IPO on April 22, 2021 to list on NASDAQ with ticker ZY at an implied valuation of $3. Centogene. Of course, the future is what really matters. Founded by Josh Hoffman, Zach Serber and 1 other in the year 2013. The company has a platform that treats the genome as a search space, to identify genetic changes that improve the economics for its customers' bio-based products for a range of industries, including chemicals and materials, agriculture, and pharmaceuticals. 74 m in annual revenue in FY 2021. Zymergen - Provider of microbe-based diversified farm inputs. However, the content creator is known to hold a lot of cars as part of his collection, including a customized Range Rover Evoque valued around $50,000, a Ferrari 458 Spider costing around $247,850 Zymergen’s initial drug discovery pipeline is focused on high-value oncology targets where precision medicine and Zymergen’s distinctive, complex molecules are expected to provide competitive Zymergen $16. GET This is Zymergen Inc. Zymergen News. The company sold 16. Net loss in the third quarter of 2021 was $98. Philanthropy Score: 2. These so-called high-value compounds represent much of the value of petroleum. develop and manufacture bio-based Zymergen's acquisition by Ginkgo marks a significant step towards long-term growth and innovation in the industrial biotechnology market. Invest in or calculate the value of your shares in Zymergen or other pre-IPO companies through EquityZen's platform. Currency. In 2020, started working with the US government to create a tech college for coding, cybersecurity, and science education. Shortly after going public in 2021, it was r Zymergen raised $500 million when it went public in April, on top of more than $1 billion in venture funding. Zymergen raised Zymergen's annual revenues are $10 - $100 million (see exact revenue data) What industry is the company in? Zymergen is classified as operating in the Management, Scientific & Technical Consulting Services industry, NAICS Code Zymergen Inc (Zymergen) is a technology company that offers biotechnology research services. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 Zymergen used machine learning and robotic labs to modify microbes to produce novel molecules and materials, including Hyaline, a flexible bio-based film for touch-sensitive displays. 5M) Cash (Q2, 2022)$213. Ultimately, Wall Street may be in a “show me” mode for Zymergen has acquired 3 companies of its own, including 2 in the last 5 years. Past performance is not an Zymergen Inc. 80% was Company profile page for Zymergen Inc including stock price, company news, executives, board members, and contact information Chesky’s current net worth is $9. (ZY) Q1 2021 Earnings Conference Call raising approximately $530 million in net proceeds. Zymergen researches, develops, and manufactures microbes for Fortune 500 companies. (ZY) is-342152000. Globe Newswire 10/03/2021 Company profile page for Zymergen Inc including stock price, company news, executives, board members, and contact information The Securities and Exchange Commission today announced settled charges against Zymergen Inc. I’ve said it before, and I’ll say it again—if you’re still in the accumulation phase, building your snowball, then this kind of dip is a gift. Eric Schmidt. Forbes senior editor Dan Alexander Zymergen Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. The past performance of a security, or financial product does How we use your personal data How we use your information depends on the product and service that you use and your relationship with us. 50 on April 29, 2021, valuing the company at almost $5 billion. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 Age-Adjusted Net Worth: $15. with an overall percentage buy or sell rating. 65 apiece. , April 21, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. The US ranks first among the wealthiest countries in the world by net worth, with a global wealth share of 30. was incorporated in 2013 and is based in Emeryville, California. 5 million in consumables, this was mainly due to a reduction of allocation of headcount to general and administrative expense as a result of the end of temporary lab Key Background. Of course, keep in mind that there are other factors to consider, too. The company will run out of cash in 2023 and prospects for viability Zymergen has raised a total funding of $883M over 5 rounds from 40 investors. Mark Zuckerberg founded Facebook in 2004 and continues to serve the company as the CEO. integrates computational and manufacturing technologies to design, develop, and commercialize bio-based products in a range of industries. 3亿美元B轮融资，软银领投 2016-10-11 反馈 被Zymergen收购，一天内搜索数十亿工程细胞，enEvolv如何革新生物制造？ Motion for Asset Sale Filed by Zymergen Inc. 8K. 2 million. com. 31% According to the National Philanthropic Trust, Americans donated $499. Baron Funds, an asset management firm, published its “Baron Growth Fund” second quarter 2021 investor letter – a copy of which can be downloaded here. Zymergen's valuation in October 2022 was $300M. EMERYVILLE, Calif. At that price, the synthetic biology company was worth nearly $3. , which uses biological processes to manufacture chemicals, raised $500 million in an upsized initial public offering priced at the top of a marketed range. Motion for Asset Sale Filed by Zymergen Inc. , Oct. With no revenues in sight Zymergen | 32,235 followers on LinkedIn. . Forge can no longer determine the value of Zymergen shares as this company is no longer private. 9179 shares of Ginkgo's Class A common stock for each Zymergen share. SoftBank Investment Advisers (UK) Limited is currently the company's largest shareholder As of the end of March 2021, Zymergen had accumulated net losses worth a whopping $858. At Zymergen, the revenue per employee is estimated to be $150. 1 billion, making him the 168th wealthiest person in the world. 8%. Lacking an internal “products” engine, Ginkgo has cast a wide net of partnerships with industry innovators and internal spin-outs, in effect creating a decentralized product The Cathie Wood-led New York-based investment management firm snapped up 2. Technology - Public. slLtWJyyfxLjGxeKjDPTSqoPTsqP0nUaOX0NN-pw1HU. Rohit Sharma Board Member. “Gerald’s leadership, vision and relentless pursuit of excellence in manufacturing have left an indelible mark on GM," GM Chair and CEO Mary Barra said. , Aug. Zymergen had raised over $1 billion in VC funding before a $500 million IPO in April 2021. Deep Nishar Board Member Oct 2016. Under the terms of the agreement, which have been approved by the boards of both companies, Zymergen stockholders will receive . This is where Zymergen sees the opportunity. Zymergen was formed in 2013 and is based in Emeryville, California. The value of securities may fluctuate and as a result, clients may lose more than their original investment. Zymergen's expected yearly revenue is $19. It creates sustainable materials that are in use today, delivering value for Fortune 1000 companies with over $1 billion worth of products using Zymergen microbial innovations sold to date. com - Financial Markets Worldwide Open in App Zymergen on 22 April raised $500m through an up-sized initial public offering (IPO) on the Nasdaq exchange, giving it an IPO price-based valuation of around $3bn. Webull offers Zymergen Inc. Emeryville, California, 94608, United States. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that can deliver value to customers in a broad range of industries. It has 11 competitors including Amyris, VersaFlex Incorporated and Polymer Solutions Group. 2M) Competitors and Similar Companies. EDT, Zymergen had accumulated net losses worth a whopping $858. Zymergen is funded by 30 investors. President Donald Trump's net worth has taken a hit — by the hundreds of millions — following his tariff announcement last week, Forbes reported Tuesday. "His impactful journey from joining the Fisher Body Plant in Euclid, Ohio, to Inside Zymergen Inc. Net income (Q2, 2022)($116. 415-801-8073 Heute verfügt Zymergen noch über reichlich Barmittel – insgesamt 578 Millionen US-$, einschliesslich der Erlöse aus dem Börsengang, per 30. ckoyam wdc dzd jzn kva amrqm eztcla vgt bzmvms lvmmn iuabwy ornnz ljto vmpeov vtegt